CCA
JAZZ icon

Checchi Capital Advisers’s Jazz Pharmaceuticals JAZZ Stock Holding History

Checchi Capital Advisers’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-186
Closed -$26K – 801
2016
Q2 		$26K Buy
186
+6
+3% +$885 ﹤0.01% 1104
2016
Q1 		$23K Buy
+180
New +$22.4K 0.01% 1082

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Checchi Capital Advisers's JAZZ Position: Q3 2016 in Review

Checchi Capital Advisers sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2016, closing a stake of 186 shares — an estimated $26K sold.

Checchi Capital Advisers first reported a position in JAZZ in Q1 2016 and held it in 2 quarters. The position peaked at $26K in Q2 2016. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

  • Checchi Capital Advisers reported no remaining Jazz Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Checchi Capital Advisers sold 186 Jazz Pharmaceuticals shares in Q3 2016, an estimated $26K.
  • Checchi Capital Advisers first reported a position in Jazz Pharmaceuticals in Q1 2016 and held it in 2 quarters.
  • Checchi Capital Advisers's Jazz Pharmaceuticals position peaked at $26K in Q2 2016.
  • 325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on Checchi Capital Advisers's 13F filing for Q3 2016, filed 10 Nov 2016.